İftahar Köksal

Prof. İftahar Köksal is an experienced physician specializing in infectious diseases and clinical microbiology. He earned his medical degree from Texas Tech University School of Medicine in 1992 and has since built a career focused on infection prevention, liver disease, and clinical microbiology. In 2022 he joined Acibadem Health Group, where he contributes clinical expertise and patient care. He is an active member of several professional societies, including the Turkish Society for Hospital Infections and Control, the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey, and the Association for the Fight Against Viral Hepatitis. His international memberships include the European Society of Clinical Microbiology and Infectious Diseases, the American Association for the Study of Liver Diseases, and the European Association for the Study of the Liver. Prof. Köksal combines a strong clinical background with engagement in professional organizations to support best practices in infection control, hepatology, and clinical microbiology.

Education

• 1992 United States Texas Technical University Medical School
• 1987 Hacettepe University Faculty of Medicine Infectious Diseases and Clinical Microbiology
• 1981 Dicle University Faculty of Medicine

Experience

• 2022 Acibadem Health Group
• 2018 – 2020 Karadeniz Technical University Clinical Research Center Director
• 1998 – 2020 Karadeniz Technical University Faculty of Medicine / Prof.Dr.
• 2001 – 2015 Karadeniz Technical University Faculty of Medicine, Infection Control Committee
• 1992 – 1998 Karadeniz Technical University Faculty of Medicine / Assoc. Prof. Dr.
• 1988 – 1992 Karadeniz Technical University Faculty of Medicine / Assistant. Assoc. Prof. Dr. / Founder

Memberships

• Turkish Society for Hospital Infections and Control
• European Society Clinical Microbiology and Infectious Diseases
• Infectious Diseases and Clinical Microbiology Specialty Society of Turkey
• Association for the Fight Against Viral Hepatitis
• American Association for the Study of Liver Diseases
• European Association for the Study of the Liver

Publications

• The “MICE” scoring system in differentiating the identical twins leptospirosis and hantavirus infection
  Infection. 2020 Feb;48(1):99-107. doi: 10.1007/s15010-019-01366-7. Kaya S, Yilmaz G, Aydin M, Aksoy F, Koksal I.
• RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.
  Young K, Kartsonis NA, Butterton JR, Paschke A.Clin Infect Dis. 2019 Aug 10. pii: ciz530. doi: 10.1093/cid/ciz530. Motsch J, Murta de Oliveira C, Stus V, Köksal I, Lyulko O, Boucher HW, Kaye KS, File TM, Brown ML, Khan I, Du J, Joeng HK, Tipping RW, Aggrey A,
• Early Access Program (EAP) Study Group. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort
  Ataseven H, Akdogan M, Kiyici M, Koksal AS, Akhan S, Gunsar F, Tabak F, Kaymakoglu S, Akarca US.J Viral Hepat. 2019 Jun;26(6):666-674. doi: 10.1111/jv Idilman R, Demir M, Aladag M, Erol C, Cavus B, Iliaz R, Koklu H, Cakaloglu Y, Sahin M, Ersoz G, Koksal I, Karasu Z, Ozgenel M, Turan I, Gunduz F,
• Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional observational study
  Kuruüzüm Z, Tarakçı H, Beslen N, Erdoğan S, Özdener F, Study Group TCHC. Turk J Gastroenterol. 2018 Jul;29(4):464-472. doi: 10.5152/tjg.2018.16597 Köksal İ, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydoğdu Ö, Turgut H, Gürbüz Y, Dağlı Ö, Gökal AA, Güner R,
• Carbonic anhydrase I-II autoantibodies and oxidative status in long-term follow-up of patients with Crimean-Congo haemorrhagic fever.
  Arch Physiol Biochem. 2018 Feb;124(1):69-74. Yilmaz H, Kostakoğlu U, Demir S, Aksoy F, Menteşe A, Karahan SC, Köksal İ, Alver A, Yilmaz G.
• Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.
  Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263. Aygen B, Demir AM, Gümüş M, Karabay O, Kaymakoğlu S, Köksal AŞ, Köksal İ, Örmeci N, Tabak F.
• Importance of endothelial dysfunction biomarkers in patients with Crimean-Congo hemorrhagic fever
  J Med Virol. 2017 Dec;89(12):2084-2091. Arslan M, Yilmaz G, Mentese A, Yilmaz H, Karahan SC, Koksal I.
• The importance of risk factors for the prediction of patients with invasive pulmonary aspergillosis
  Rev Assoc Med Bras 2017 Sep;63(9):764-770. Kaya S, Gencalioglu E, Sonmez M, Koksal I.
• The prognostic significance of serum TGF-ß1 levels in patients with Crimean-Congo hemorrhagic fever
  J Med Virol. 2017 Mar;89(3):413-416. Yilmaz G, Yilmaz H, Arslan M, Kostakoğlu U, Menteşe A, Karahan SC, Köksal İ.
• The pilgrimage and the burden of pneumococcal disease in adults
  Tuberk Thoraks. 2017 Dec;65(4):327-332. doi: 10.5578/tt.40365. Turkish Köksal İ, Şenol E, Çilli A, Alıcı DE.